BioVaxys Technology Corp. BVAXF

Primary Symbol: C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Jun 17, 2022 10:37am

131 Views

Post# 34764279

BIOV I GOT MY FILL THANK YOU!! HAPPY FOR THOSE WHO GOT @.095

DANG RIGHT I'M happy as long as the shares are in strong hands and PROGRESS is continuing to move and shareholders are continuing to be informed....my money staying right here until I get what I came for ....ROI$$$$$$$$

SHOUT OUT LONGS!! top of the day to ya Franky! :>))

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand